Literature DB >> 25694496

Soft tissue sarcoma, non-Hodgkin's lymphoma and chronic lymphocytic leukaemia in workers exposed to phenoxy herbicides: extended follow-up of a UK cohort.

David Coggon1, Georgia Ntani1, E Clare Harris1, Nimeshi Jayakody1, Keith T Palmer1.   

Abstract

OBJECTIVES: To provide further information on the possible carcinogenicity of phenoxy herbicides, and in particular their relationship to soft tissue sarcoma (STS), non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukaemia (CLL).
METHODS: We extended follow-up to December 2012 for 8036 men employed at five factories in the UK which had manufactured phenoxy herbicides, or in a contract spraying business. Mortality was compared with that for England and Wales by the person-years method. Nested case-control analyses compared men with incident or fatal STS (n=15) or NHL/CLL (n=74) and matched controls (up to 10 per case).
RESULTS: 4093 men had died, including 2303 since the last follow-up. Mortality from all causes and all cancers was close to expectation, but an excess of deaths from NHL was observed among men who had worked for ≥1 year in jobs with more than background exposure to phenoxy herbicides (19 deaths, SMR 1.85, 95% CI 1.12 to 2.89). Four deaths from STS occurred among men potentially exposed above background (3.3 expected). In the nested case-control analyses, there were no significantly elevated risks or consistent trends across categories of potential exposure for either STS or NHL/CLL. Among men who had worked for ≥1 year in potentially exposed jobs, the highest OR (for STS) was only 1.30 (95% CI 0.30 to 5.62).
CONCLUSIONS: Our findings are consistent with the current balance of epidemiological evidence. If phenoxy herbicides pose a hazard of either STS or NHL, then any absolute increase in risk is likely to be small. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25694496      PMCID: PMC4445603          DOI: 10.1136/oemed-2014-102654

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  13 in total

1.  Mortality and incidence of cancer at four factories making phenoxy herbicides.

Authors:  D Coggon; B Pannett; P Winter
Journal:  Br J Ind Med       Date:  1991-03

2.  Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study.

Authors:  M Kogevinas; H Becher; T Benn; P A Bertazzi; P Boffetta; H B Bueno-de-Mesquita; D Coggon; D Colin; D Flesch-Janys; M Fingerhut; L Green; T Kauppinen; M Littorin; E Lynge; J D Mathews; M Neuberger; N Pearce; R Saracci
Journal:  Am J Epidemiol       Date:  1997-06-15       Impact factor: 4.897

3.  Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols.

Authors:  R Saracci; M Kogevinas; P A Bertazzi; B H Bueno de Mesquita; D Coggon; L M Green; T Kauppinen; K A L'Abbé; M Littorin; E Lynge
Journal:  Lancet       Date:  1991-10-26       Impact factor: 79.321

4.  Soft-tissue sarcomas and exposure to chemical substances: a case-referent study.

Authors:  M Eriksson; L Hardell; N O Berg; T Möller; O Axelson
Journal:  Br J Ind Med       Date:  1981-02

Review 5.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

6.  Mortality of workers exposed to 2 methyl-4 chlorophenoxyacetic acid.

Authors:  D Coggon; B Pannett; P D Winter; E D Acheson; J Bonsall
Journal:  Scand J Work Environ Health       Date:  1986-10       Impact factor: 5.024

Review 7.  Phenoxy herbicides, soft-tissue sarcoma and non-Hodgkin lymphoma: a systematic review of evidence from cohort and case-control studies.

Authors:  Nimeshi Jayakody; E Clare Harris; David Coggon
Journal:  Br Med Bull       Date:  2015-03-19       Impact factor: 4.291

8.  Case-control study: soft-tissue sarcomas and exposure to phenoxyacetic acids or chlorophenols.

Authors:  L Hardell; A Sandström
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

Review 9.  Weight of the evidence on the human carcinogenicity of 2,4-D.

Authors:  M A Ibrahim; G G Bond; T A Burke; P Cole; F N Dost; P E Enterline; M Gough; R S Greenberg; W E Halperin; E McConnell
Journal:  Environ Health Perspect       Date:  1991-12       Impact factor: 9.031

10.  Malignant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: a case-control study.

Authors:  L Hardell; M Eriksson; P Lenner; E Lundgren
Journal:  Br J Cancer       Date:  1981-02       Impact factor: 7.640

View more
  4 in total

1.  Passive exposure to agricultural pesticides and risk of childhood leukemia in an Italian community.

Authors:  Carlotta Malagoli; Sofia Costanzini; Julia E Heck; Marcella Malavolti; Gianfranco De Girolamo; Paola Oleari; Giovanni Palazzi; Sergio Teggi; Marco Vinceti
Journal:  Int J Hyg Environ Health       Date:  2016-09-21       Impact factor: 5.840

Review 2.  Establishing a role for environmental toxicant exposure induced epigenetic remodeling in malignant transformation.

Authors:  Kristen M Humphrey; Sumali Pandey; Jeffery Martin; Tamara Hagoel; Anne Grand'Maison; Joyce E Ohm
Journal:  Semin Cancer Biol       Date:  2018-11-16       Impact factor: 15.707

3.  A Perspective Discussion on Rising Pesticide Levels and Colon Cancer Burden in Brazil.

Authors:  Sergio Akira Uyemura; Helga Stopper; Francis L Martin; Vinicius Kannen
Journal:  Front Public Health       Date:  2017-10-16

4.  Exposures to 2,4-Dichlorophenoxyacetic acid with or without endotoxin upregulate small cell lung cancer pathway.

Authors:  Geetika Kaur; B V Sunil Kumar; Baljit Singh; R S Sethi
Journal:  J Occup Med Toxicol       Date:  2021-04-17       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.